Clinical Trial: A Study of DS-7011a in Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
Study Status: Completed
Recruit Status: RECRUITING
Condition: Systemic Lupus Erythematosus
Study Type: INTERVENTIONAL
Official Title: A Phase 1b/2, Double-Blind, Placebo-Controlled, Randomized, Parallel-Arm Study to Explore the Safety, Pharmacokinetics, and Proof of Biological Activity of DS-7011a in Patients With Systemic Lupu
Brief Summary:
Systemic lupus erythematosus (SLE) is a systemic chronic autoimmune disease characterized by autoantibody production, inflammation, and tissue damage in multiple organs.Standard of care therapies used to treat SLE are only partially effective and have a wide range of toxicities.There is a need for more effective and safer therapies for patients with SLE.
Read more